Health Trials

Sitagliptin or BeiDouGen Capsule Improve the Pregnancy Outcome in Patients with PCOS

ConditionPolycystic Ovarian Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-40
SponsorPeking University Third Hospital

About this trial

This study will be carried out under the guidance of professional doctor, patients with PCOS will be treated with Sitagliptin or BeiDouGen capsule or both two to assess their ovarian function and reproductive outcomes, and compare the effect of different treatment methods, which will provide the basis for PCOS intervention strategy and related research

Eligibility criteria

Qualifiers

Female patients aged 20-40 years who plan to conceive or are infertile in our center.

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Sitagliptin
  • BeiDouGen
  • Sitagliptin+BeiDouGen

Treatment groups

300 Participants
are divided into 3 treatment groups

Sponsors and collaborators

Peking University Third Hospital

Lead sponsor

Source ClinicalTrials.gov